StockNews.AI
BPMC
StockNews.AI
77 days

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

1. BPMC is proposed for sale to Sanofi at $129 per share. 2. Shareholders will receive contingent value rights tied to BLU-808's milestones. 3. KSF is investigating if the deal undervalues BPMC. 4. The transaction is structured as a tender offer; timely action advised. 5. Legal advice offered for shareholders who feel undervalued.

3m saved
Insight
Article

FAQ

Why Bullish?

The $129 offer exceeds BPMC's recent trading prices, indicating potential upside.

How important is it?

The investigation may influence shareholders' perception and acceptance of the deal.

Why Short Term?

Pending investigation may influence immediate market sentiment and trading activity.

Related Companies

SNY
- NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Blueprint Medicines Corporation (NasdaqGS: BPMC) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Blueprint will receive $129.00 per share in cash at closing, and also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-bpmc/ to learn more. Please note that the transaction is structured as a tender offer, such that time may be of the essence. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. More News From Kahn Swick & Foti, LLC

Related News